ALTO-100 in MDD and/or PTSD
Public ClinicalTrials.gov record NCT05117632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Study of ALTO-100 in Adults With Major Depressive Disorder and/or Post-traumatic Stress Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this study is to collect biologically based data for defining predictors and correlates of the effects of ALTO-100.
Study identification
- NCT ID
- NCT05117632
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 245 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 20, 2021 (Actual)
- Primary completion
- Dec 1, 2022 (Actual)
- Completion
- Dec 9, 2022 (Actual)
- Last update posted
- Dec 1, 2023
2021 – 2022
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 136 | Tempe | Arizona | 85284 | — |
| Site 139 | Little Rock | Arkansas | 72211 | — |
| Site 141 | Costa Mesa | California | 92626 | — |
| Site 118 | Fresno | California | 93703 | — |
| Site 116 | Martinez | California | 94553 | — |
| Site 116 | Mather | California | 95655 | — |
| Site 150 | Boca Raton | Florida | 33431 | — |
| Site 112 | Doral | Florida | 33172 | — |
| Site 155 | Elgin | Illinois | 60123 | — |
| Site 137 | Noblesville | Indiana | 46060 | — |
| Site 151 | Baltimore | Maryland | 21229 | — |
| Site 109 | Belmont | Massachusetts | 02478 | — |
| Site 108 | Jackson | Mississippi | 39216 | — |
| Site 142 | Lincoln | Nebraska | 68526 | — |
| Site 144 | Las Vegas | Nevada | 89102 | — |
| Site 146 | Middleburg Heights | Ohio | 44130 | — |
| Site 147 | Fort Worth | Texas | 76104 | — |
| Site 148 | Fort Worth | Texas | 76244 | — |
| Site 120 | Houston | Texas | 77054 | — |
| Site 113 | Houston | Texas | 77090 | — |
| Site 121 | Draper | Utah | 84020 | — |
| Site 105 | Seattle | Washington | 98104 | — |
| NTC Seattle (105a) | Tacoma | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05117632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05117632 live on ClinicalTrials.gov.